Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
10/31/2021
10/31/2020
Revenus
1
1
0
0
0
0
Croissance des revenus (H/H)
--
--
--
--
--
--
Coût des ventes
0
0
0
0
--
--
Bénéfice brut
0
0
0
0
--
--
Vente, Général et Administration
2
1
1
2
0
0
Recherche et développement
0
0
0
0
--
--
Frais d'exploitation
2
1
1
2
0
0
Autres revenus (charges) non opérationnels
--
0
0
0
--
--
Bénéfice avant impôts
-1
-1
-1
-4
0
0
Charge d'impôt sur le revenu
--
--
--
--
--
--
Bénéfice net
-1
-1
-1
-4
0
0
Croissance du bénéfice net
0%
0%
-75%
--
--
--
Actions en circulation (diluées)
51.06
44.31
38.38
35.28
3.18
7.18
Variation des actions (H-H)
14%
15%
9%
1,009%
-56%
20%
EPS (dilué)
-0.02
-0.02
-0.03
-0.13
-0.03
-0.01
Croissance du EPS
-23%
-28.99%
-73%
347%
90%
1,700%
Flux de trésorerie libre
0
0
-1
-1
0
0
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
0%
0%
0%
0%
--
--
Marge opérationnelle
-100%
-100%
0%
0%
0%
0%
Marge bénéficiaire
-100%
-100%
0%
0%
0%
0%
Marge du flux de trésorerie libre
0%
0%
0%
0%
0%
0%
EBITDA
-1
-1
-1
-2
--
--
Marge EBITDA
-100%
-100%
0%
0%
--
--
D&A pour le résultat opérationnel
0
0
0
0
--
--
EBIT
-1
-1
-1
-2
0
0
Marge EBIT
-100%
-100%
0%
0%
0%
0%
Taux d'imposition effectif
--
--
--
--
--
--
Statistiques clés
Clôture préc.
$0.2917
Prix d'ouverture
$0.2298
Plage de la journée
$0.219 - $0.2299
Plage de 52 semaines
$0.1169 - $0.2937
Volume
--
Volume moyen
5.6K
BPA (TTM)
--
Rendement en dividend
--
Capitalisation boursière
$13.0M
Qu’est-ce que FRECF ?
Frequency Exchange Corp. develops and commercializes frequency emitters. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2020-05-08. The firm is focused on the development and global commercialization of a wearable frequency delivery system. The Company’s specialized frequency sets are designed to enhance wellness and improve performance. The firm offers NIKKI, which is the fifth-generation frequency emitter released by the Company. Its Wave 1 is the third-generation frequency emitter released from FREmedica, specifically to deliver a Frequency Support Program to help clients with the symptoms of chronic Lyme disease. The company also expanded its frequency program through the development of a wearable frequency emitter that delivers special frequency sets designed for the consumer general wellness and performance enhancement market, specifically to target better sleep, less stress and anxiety, pain and inflammation.